Journal of Interventional Radiology (JVIR)

The website from which you got to this page is protected by Cloudflare. Email addresses on that page have been hidden in order to keep them from being accessed by malicious bots. You must enable Javascript in your browser in order to decode the e-mail address. If you have a website and are interested in protecting it in a similar way, you can sign up for Cloudflare.

This paper is only available as a PDF. To read, Please Download here. The authors have no conflicts of interest or financial disclosures to report. The enclosed content has not been presented by the authors at an SIR meeting. © 2023 Published by Elsevier, Inc., on behalf of SIR.

This paper is only available as a PDF. To read, Please Download here. © 2023 Published by Elsevier, Inc., on behalf of SIR.

All Authors have no conflicts of interest or financial Disclosures related to the submission. This was not presented at the SIR Annual Meeting

Introduction The detrimental effects of radiation exposure to physicians have been well documented and are an active area of concern. The objective of this study was to evaluate the radiation protection offered by an exoskeleton-based radiation protection system (StemRad MD, StemRad Ltd, Israel). Methods The experimental setup involved two anthropomorphic phantoms, an operator and a patient, and a C-arm as the X-ray radiation source.

To compare tumor and ice-ball margin visibility on intraprocedural PET/CT and CT-only images, and report technical success, local tumor progression, and adverse events rates for PET/CT-guided cryoablation procedures of musculoskeletal tumors. This HIPAA-compliant, IRB-approved retrospective study evaluated 20 PET/CT-guided cryoablation procedures performed with palliative and/or curative intent to treat 15 musculoskeletal tumors in 15 patients from 2012-21.

Purpose To compare the effectiveness, adverse events (AE), stent patency, and patient survival with suprapapillary and transpapillary uncovered self-expandable metallic stent placement for perihilar cholangiocarcinoma. Materials and methods A single-center retrospective study of 54 patients with inoperable perihilar cholangiocarcinoma who underwent percutaneous transhepatic biliary stenting between January 1st, 2019 and August 31st, 2021 was conducted.

This paper is only available as a PDF. To read, Please Download here. Meeting presentation: Material was not presented at an SIR meeting. © 2023 Published by Elsevier, Inc., on behalf of SIR.

This paper is only available as a PDF. To read, Please Download here. The authors have no conflicts of interests or disclosures to report.